Jeffrey E. Russel

Array ( [id] => 3695332 [patent_doc_number] => 05618792 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-08 [patent_title] => 'Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase' [patent_app_type] => 1 [patent_app_number] => 8/345820 [patent_app_country] => US [patent_app_date] => 1994-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25365 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 282 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/618/05618792.pdf [firstpage_image] =>[orig_patent_app_number] => 345820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4076775 [patent_doc_number] => 05965694 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Somatostatin mimics and synthetic methods therefor' [patent_app_type] => 1 [patent_app_number] => 8/340208 [patent_app_country] => US [patent_app_date] => 1994-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3837 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965694.pdf [firstpage_image] =>[orig_patent_app_number] => 340208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3728206 [patent_doc_number] => 05700905 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-23 [patent_title] => 'Synthetic somatostatin mimics' [patent_app_type] => 1 [patent_app_number] => 8/338890 [patent_app_country] => US [patent_app_date] => 1994-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3756 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/700/05700905.pdf [firstpage_image] =>[orig_patent_app_number] => 338890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3561963 [patent_doc_number] => 05525590 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-11 [patent_title] => 'Cyclosporins and their use as pharmaceuticals' [patent_app_type] => 1 [patent_app_number] => 8/337346 [patent_app_country] => US [patent_app_date] => 1994-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19569 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/525/05525590.pdf [firstpage_image] =>[orig_patent_app_number] => 337346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3658776 [patent_doc_number] => 05623051 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'Methods and compositions for screening for presynaptic calcium channel blockers' [patent_app_type] => 1 [patent_app_number] => 8/337602 [patent_app_country] => US [patent_app_date] => 1994-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 7693 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/623/05623051.pdf [firstpage_image] =>[orig_patent_app_number] => 337602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3533318 [patent_doc_number] => 05556836 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-17 [patent_title] => 'Use of D-glucopyranuronic acids and their derivatives for incorporation in pharmacologically active peptides and their salts' [patent_app_type] => 1 [patent_app_number] => 8/332071 [patent_app_country] => US [patent_app_date] => 1994-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8462 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/556/05556836.pdf [firstpage_image] =>[orig_patent_app_number] => 332071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3682404 [patent_doc_number] => 05633230 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'Treatment of cytomegalovirus infection' [patent_app_type] => 1 [patent_app_number] => 8/332518 [patent_app_country] => US [patent_app_date] => 1994-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 9824 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/633/05633230.pdf [firstpage_image] =>[orig_patent_app_number] => 332518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3552954 [patent_doc_number] => 05574006 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-12 [patent_title] => 'Nasally administrable peptide compositions on hydroxyapatite carriers' [patent_app_type] => 1 [patent_app_number] => 8/325652 [patent_app_country] => US [patent_app_date] => 1994-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3648 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/574/05574006.pdf [firstpage_image] =>[orig_patent_app_number] => 325652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3807660 [patent_doc_number] => 05830998 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function' [patent_app_type] => 1 [patent_app_number] => 8/323436 [patent_app_country] => US [patent_app_date] => 1994-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 21 [patent_no_of_words] => 22478 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830998.pdf [firstpage_image] =>[orig_patent_app_number] => 323436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3524709 [patent_doc_number] => 05527775 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-18 [patent_title] => 'Reduction of mammalian neoplasms with phospholipase A2 activating substances' [patent_app_type] => 1 [patent_app_number] => 8/323444 [patent_app_country] => US [patent_app_date] => 1994-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6171 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/527/05527775.pdf [firstpage_image] =>[orig_patent_app_number] => 323444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3504242 [patent_doc_number] => 05514562 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-07 [patent_title] => 'Method and an apparatus for currently measuring the presence of traces of an undesirable substance in air' [patent_app_type] => 1 [patent_app_number] => 8/318569 [patent_app_country] => US [patent_app_date] => 1994-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3083 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/514/05514562.pdf [firstpage_image] =>[orig_patent_app_number] => 318569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3647869 [patent_doc_number] => 05629282 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-13 [patent_title] => 'Antibacterial compositions' [patent_app_type] => 1 [patent_app_number] => 8/317275 [patent_app_country] => US [patent_app_date] => 1994-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5521 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/629/05629282.pdf [firstpage_image] =>[orig_patent_app_number] => 317275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3658620 [patent_doc_number] => 05627156 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-06 [patent_title] => 'Polypeptide agonists for human interleukin-8' [patent_app_type] => 1 [patent_app_number] => 8/311307 [patent_app_country] => US [patent_app_date] => 1994-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 11174 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 267 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/627/05627156.pdf [firstpage_image] =>[orig_patent_app_number] => 311307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3612377 [patent_doc_number] => 05565431 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-15 [patent_title] => 'Cancer cell inhibitors and method' [patent_app_type] => 1 [patent_app_number] => 8/310341 [patent_app_country] => US [patent_app_date] => 1994-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4905 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/565/05565431.pdf [firstpage_image] =>[orig_patent_app_number] => 310341 [rel_patent_id] =>[rel_patent_doc_number] =>)